ValueRich Report on AMDL/China Available on Web Site
October 08 2007 - 10:35AM
PR Newswire (US)
TUSTIN, Calif., Oct. 8 /PRNewswire-FirstCall/ -- AMDL, Inc.
(AMEX:ADL), headquartered in Tustin, California, with operations in
Shenzhen, Jiangxi and Jilin, China, through its wholly owned
subsidiary Jade Pharmaceutical Inc., is an international biopharma
company that engages in the development, manufacture and marketing
of proprietary pharmaceutical and diagnostic products. AMDL
announced today that a detailed report on the Company, its
prospects in China, its products and technologies, and its history
is available at
http://www.ivaluerich.com/profile_company.php?id=3785 "The report
includes significant information on investing in Chinese
pharmaceutical companies, why AMDL resembles other companies than
have been successful, background on the Company's Jade
Pharmaceutical subsidiary, our DR-70(R) cancer test kit and our
Combination Immunogene Therapy to assist a cancer patient's immune
system to attack and kill cancer cells," said Gary Dreher, AMDL
CEO. "We believe this information will be of interest to our
shareholders and potential investors." About AMDL: More information
about AMDL and its products can be obtained at http://www.amdl.com/
. Forward-Looking Statements: This news release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such statements are
subject to certain risks and uncertainties, and actual
circumstances, events or results may differ materially from those
projected in such forward-looking statements. The Company cautions
readers not to place undue reliance on any forward-looking
statements. The Company does not undertake, and specifically
disclaims any obligation, to update or revise such statements to
reflect new circumstances or unanticipated events as they occur.
Contact: AMDL, Inc. Paul Knopick AMDL Investor Relations Direct
Line: 949.707.5365 Voice Mail: 714.505.4460 DATASOURCE: AMDL, Inc.
CONTACT: Paul Knopick for AMDL Investor Relations, +1-949-707-5365,
Voice Mail, +1-714-505-4460 Web site: http://www.amdl.com/
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From May 2024 to Jun 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2023 to Jun 2024